 | • レポートコード：D0-MOR-AP0614 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：食品＆飲料 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、グルコサミンの世界市場について調査・分析した資料で、グルコサミンの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
Market Overview
The Global Glucosamine Market is projected to register a CAGR of 3.8% over the forecast period (2020-2025). Glucosamine is a common supplement used for the treatment of knee osteoarthritis.
– Glucosamine is legally regarded as a dietary supplement in the United States. However, it is a prescribed drug in Europe. Increased sedentary lifestyle among the general population in these regions is increasing the incidence of bone and joint conditions which has propped up the market for bone and joint supplements such as glucosamine.
– Glucosamine is also being used in combination with other ingredients such as collagen peptides, hyaluronic acid, vitamins, and traditional herbs. The increased health consciousness of consumers is expected to propel the market for glucosamine further during the forecast period.
Scope of the Report
The Global Glucosamine Market is segmented by application into food and beverages, nutritional supplements, dairy products, and other applications. The market is segmented by geography to include the market trends of top countries in North America, Europe, Asia-Pacific, South America and Middle-East & Africa.
Key Market Trends
Increased Usage in Bone and Joint Health Supplements
The World Health Organization (WHO) has estimated that almost 22 million individuals in Europe and 14 million in the United States alone will be suffering from osteoporosis. In 2017, it was observed that more than 200 million people suffered from osteoporosis. Bone and Joint Health Supplements target the aging population and the percentage of population above the age of 65 is significantly high in regions such as North America and Europe. Maintaining a healthy lifestyle and preventing age-related bone diseases particularly at an older age is making consumers pay premium prices for these supplements, as they impart health benefits, targeting treatment of a specific segment of the human body. This trend is certainly continuing, with the rise of simpler, cleaner, and free-from label bone and joint health supplements, as an indicator of the increase in the popularity and acceptance of the natural products. The essential properties of glucosamine have encouraged the manufacturers to introduce new products and thus, lead to the overall growth of the glucosamine market. For instance, global wellness and direct sales leader XANGO launched Xango Aeries Marine Collagen Complex, which is a blend of pure hydrolyzed marine collagen peptides with hyaluronic acid, glucosamine, vitamin C, and traditional herbs to promote healthy skin, hair, joints, and bones.
Europe Leading the Global Market
Europe has several factors conducive to the growth of the glucosamine market. The region has the highest number of people living with osteoarthritis. The World Health Organization (WHO) estimates that between 10% to 15% of the population aged 60 years and above have some form of osteoarthritis. Also, the awareness level of the general population towards health and wellness supplements, especially those used for bone and joint health are high. These factors are increasingly driving the market for glucosamine in the region.
Competitive Landscape
The Global Glucosamine Market is fragmented with global companies competing fiercely with local companies to gain market share. The companies active in the market are not only looking for organic growth through product innovations and geographical expansion, but are also on the lookout for opportunistic acquistions.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
3.1 Market Overview
4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Force Analysis
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Application
5.1.1 Food & Beverages
5.1.2 Nutritional Supplements
5.1.3 Dairy Products
5.1.4 Other Appkications
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.1.4 Rest of North America
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Spain
5.2.2.5 Russia
5.2.2.6 Italy
5.2.2.7 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 Rest of Asia-Pacific
5.2.4 South America
5.2.4.1 Brazil
5.2.4.2 Argentina
5.2.4.3 Rest of South America
5.2.5 Middle East and Africa
5.2.5.1 Saudi Arabia
5.2.5.2 South Africa
5.2.5.3 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Share Analysis
6.2 Most Adopted Strategies
6.3 Company Profiles
6.3.1 Koyo Chemical Co., Ltd.
6.3.2 Schiff Nutrition International Inc.
6.3.3 Zhejiang Aoxing Biotechnology Co., Ltd.
6.3.4 Panvo Organics Pvt. Ltd.
6.3.5 Golden Shell Pharmaceutical Co., Ltd.
6.3.6 Ethical Naturals, Inc.
6.3.7 FabriChem, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS